Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?

Objectives: We critically evaluated the quality of evidence and quality of harms reporting in clincal trials that recently evaluated the effectiveness of HCQ/CQ in COVID-19. Study Design and Setting: Scientific databases were systematically searched to identify relevant trials of HCQ/CQ in COVID-19...

Full description

Autores:

Tipo de recurso:

Article of investigation

Fecha de publicación:

2020

Institución:

Universidad de Bogotá Jorge Tadeo Lozano

Repositorio:

Expeditio: repositorio UTadeo

Idioma:

eng

OAI Identifier:

oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14241

Acceso en línea:

https://doi.org/10.1016/j.ijid.2020.09.1470
http://hdl.handle.net/20.500.12010/14241

Palabra clave:

Coronavirus 2019
Harm reporting
Adverse events
Hydroxychloroquine
Chloroquine
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus

Rights

License

Abierto (Texto Completo)